What is Protix?
Protix BV, headquartered in Dongen, North Brabant, Netherlands, operates within the Food & Beverages industry. The company is recognized for its innovative approach, likely focusing on sustainable food production or related technologies, given its industry and the nature of its backers. The recent major strategic investment suggests a phase of significant scaling or expansion, positioning Protix as a key player in its market segment.
How much funding has Protix raised?
Protix has raised a total of $147.8M across 3 funding rounds:
Private Equity
$50.4M
Unspecified
$57.1M
Debt
$40.3M
Private Equity (2017): $50.4M with participation from Aqua-Spark, The BOM, and Rabo Investments
Unspecified (2022): $57.1M led by BNP Paribas, The Good Investors, European Circular Bioeconomy Fund, and Invest-NL
Debt (2024): $40.3M supported by European Investment Bank
Key Investors in Protix
European Investment Bank
The European Investment Bank (EIB) is the European Union's nonprofit long-term lending and finance institution, established in 1958 and headquartered in Luxembourg. It plays a crucial role in financing projects that support EU policy objectives, including sustainable development and innovation.
BNP Paribas
BNP Paribas is a leading international banking group headquartered in Paris, France, offering a wide range of financial services including retail banking, investment banking, and insurance. It is known for its significant global presence and commitment to sustainable finance.
European Circular Bioeconomy Fund
The European Circular Bioeconomy Fund (ECBF) is a specialist venture capital firm focused on the regenerative economy, investing in pioneering companies that aim to align economic growth with environmental sustainability. They provide capital and sector expertise to support the scaling of bioeconomy solutions.
What's next for Protix?
The substantial enterprise-level funding, particularly the recent strategic investment, indicates Protix is poised for accelerated growth and market penetration. This capital infusion is expected to fuel further innovation, operational expansion, and potentially new market entries. The company's trajectory suggests a focus on solidifying its position and leveraging its technological advancements to capture greater market share. Future developments will likely involve strategic partnerships and continued investment in research and development to maintain its competitive edge.
See full Protix company page
